- Home
- BBT vs CNTA Comparison
BBT vs CNTA Comparison
Compare BBT & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBT
- CNTA
- Stock Information
- Founded
- BBT 1846
- CNTA 2020
- Country
- BBT United States
- CNTA United Kingdom
- Employees
- BBT N/A
- CNTA N/A
- Industry
- BBT Banks
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- BBT Finance
- CNTA Health Care
- Exchange
- BBT Nasdaq
- CNTA Nasdaq
- Market Cap
- BBT 2.2B
- CNTA 2.3B
- IPO Year
- BBT N/A
- CNTA 2021
- Fundamental
- Price
- BBT $24.26
- CNTA $23.50
- Analyst Decision
- BBT Hold
- CNTA Strong Buy
- Analyst Count
- BBT 1
- CNTA 8
- Target Price
- BBT $33.00
- CNTA $31.29
- AVG Volume (30 Days)
- BBT 537.9K
- CNTA 1.5M
- Earning Date
- BBT 11-08-2025
- CNTA 11-11-2025
- Dividend Yield
- BBT 2.26%
- CNTA N/A
- EPS Growth
- BBT N/A
- CNTA N/A
- EPS
- BBT 0.88
- CNTA N/A
- Revenue
- BBT $345,393,000.00
- CNTA $15,000,000.00
- Revenue This Year
- BBT $53.53
- CNTA N/A
- Revenue Next Year
- BBT $73.62
- CNTA N/A
- P/E Ratio
- BBT $27.21
- CNTA N/A
- Revenue Growth
- BBT 8.11
- CNTA 118.88
- 52 Week Low
- BBT $22.27
- CNTA $9.60
- 52 Week High
- BBT $32.36
- CNTA $24.57
- Technical
- Relative Strength Index (RSI)
- BBT N/A
- CNTA 62.03
- Support Level
- BBT N/A
- CNTA $22.26
- Resistance Level
- BBT N/A
- CNTA $24.13
- Average True Range (ATR)
- BBT 0.00
- CNTA 1.03
- MACD
- BBT 0.00
- CNTA -0.17
- Stochastic Oscillator
- BBT 0.00
- CNTA 69.75
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.